Friday 6 November 2026 Export RVTY’s income statement to Excel — free account

Revvity Inc.

RVTY Healthcare Diagnostics & Research

Revvity Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.9 billion, up 3.67% from fiscal 2024.

Revenue: +4.29%
EPS: +2.17%
Free cash flow: +27.0%
Total debt: −18.1%

Quarter to September 2026, against a year earlier

150.97 8.46 −5.31%

Follow RVTY

Alert me

Market cap: $16.8B
P/E: 71.9×
Fwd P/E: 66.2×
Dividend yield: 0.19%
F-score: 6/9
Altman Z: 2.49
Beneish M: −2.45
Dividend safety: 80/100

Overview Business Profile Earnings & Analysis Segments Valuation Filings

Revvity Inc. (RVTY) P/S ratio

Alert me on P/S ratio

As of 5 November 2026, Revvity Inc. (RVTY) trades at a P/S ratio of 5.7×. Over the past ten years it has ranged from 2.2× (February 2016) to 6.7× (January 2021); the current reading is higher than 94% of that period. That is above the Diagnostics & Research industry median of 4.2× and above the Healthcare sector median of 3.5×.

Embed this chart

Code for your page

<iframe src="https://stockrow.com/embed/RVTY/ps-ratio" width="100%" height="360" style="border:0" loading="lazy" title="Revvity Inc. P/S ratio, 10 years"></iframe>
<p style="font-size:12px">Source: <a href="https://stockrow.com/RVTY/metrics/ps-ratio">Revvity Inc. (RVTY) P/S ratio — stockrow.com</a></p>

Period	P/S ratio	Change
FY2025	3.9×	(20.61%)
FY2024	5.0×	(0.67%)
FY2023	5.0×	(6.88%)
FY2022	5.4×	(11.89%)
FY2021	6.1×	1.55%
FY2020	6.0×	61.01%
FY2019	3.7×	19.37%
FY2018	3.1×	(13.10%)
FY2017	3.6×	31.19%
FY2016	2.7×	(4.23%)

Period	P/S ratio	Change
Sep 2026	5.8×	36.02%
Jun 2026	4.3×	26.28%
Mar 2026	3.4×	(14.48%)
Dec 2025	3.9×	9.80%
43 more quarters	Free account

Against its own ten years

Low 2.2× High 6.7×

Ten-year median 3.9×

Current reading's percentile 93

Company	P/S ratio
ICLR ICON PLC compare	1.9×
LH Labcorp Holdings Inc. compare	2.0×
DGX Quest Diagnostics Incorporated compare	2.4×
CRL Charles River Laboratories International, Inc. compare	3.8×
QGEN QIAGEN N.V. compare	5.0×
RVTY Revvity Inc.	5.7×
MEDP Medpace Holdings, Inc. compare	6.2×
ILMN Illumina, Inc. compare	7.0×
GH Guardant Health, Inc. compare	16.2×
Diagnostics & Research industry median	4.2×
Healthcare sector median	3.5×
Market median	1.9×

What P/S ratio is

Price to Sales Ratio shows how much investors pay for each dollar of a company’s annual sales, whether or not it is profitable.

(Stock Price × Shares (Basic, Weighted) (latest quarter)) ÷ Revenue (TTM)

The full definition of P/S ratio →

Revvity Inc. (RVTY) P/S ratio

P/S ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/S ratio against peers

What P/S ratio is

More on RVTY

P/S ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/S ratio against peers

What P/S ratio is

More on RVTY

Stockrow Weekly